3:00
Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery | Oncotarget
Oncotarget
2:33
Regorafenib and TAS102 Synergize Against Gastrointestinal Cancers | Oncotarget
2:07
DPDT: Anticancer Activity and DNA Topoisomerase I Poisoning in Colon Cancer Cells | Oncotarget
1:24
Disruption of Retinol-Mediated IL-6 Expression in Colon Cancer-Associated Fibroblasts | Oncotarget
2:14
PDGF Cross-Signaling Indicates Bypassed Signaling in Colorectal Cancer | Oncotarget
2:51
Radiotherapy for Local Control in T3N0 Rectal Cancer | Oncotarget
2:11
Nutritional Support Attenuates Chemotherapy-Associated Muscle Toxicity | Oncotarget
1:44
HIV/HPV-Related Metastatic Colorectal Cancer Response to Nivolumab | Oncotarget
2:17
Chemoradiation Alters PD-L1, CD8+ TILs and Mucin in Rectal Cancer | Oncotarget
0:52
Oncotarget | CCL20 and Signaling Pathways in Colorectal Cancer
8:21
Oncotarget | Prolyl 4-hydroxylase Alpha 1 Protein and Early Stage Colorectal Cancer
7:07
Oncotarget | Findings offer new clues for targeting drug resistant colon cancers
2:45
Memorial Sloan Kettering Cancer Center's Dr. Hechtman talks about her Publication in Oncotarget
